Posts tagged Health Newest
ViroCell and Great Ormond Street Hospital for Children address viral vector manufacturing bottleneck
ViroCell and Great Ormond Street Hospital for Children address viral vector manufacturing bottleneck

As part of the partnership, ViroCell will more than double the UK’s lentivirus vector manufacturing capacity for clinical trials in 2022 and become the first UK CDMO to be able to deliver AAV vectors to the cell and gene therapy markets.

Read More
In the NewsFlorence BuchananCDMO, GOSH, Zayed Centre for Research, clean rooms, cell and gene therapies, 1L to 200L batch size, viral vectors, lentivirus vector, AAV vectors, CGT, gene therapy, cell therapy, Health Newest, UK CDMO, John W. Hadden II, Farzin Farzaneh